Exclusive interview from conference speaker Torsten Kneuss released ahead of SMi’s Pre-Filled Syringes and Injectable Drug Devices Conference
SMi’s Pre-Filled Syringes and Injectable Drug Devices conference, taking place on 15th-16th January 2020 in London, will bring together pharmaceutical experts, clinical researchers and manufacturers in the pre-filled syringes industry to examine innovations in device engineering and components, enhancement of human factors, and optimizing packaging and containment.
As Europe’s leading pre-filled syringe conference, the two-day event is an essential diary date for those in the industry.
During the run-up to the 2020 conference, SMi interviewed industry expert and conference speaker Torsten Kneuss, quality assurance manager combination products of Bayer. Here is a snapshot of what was discussed:
What do you see as the greatest challenge for you to overcome personally in the pre-filled syringes field at the moment?
“There is not one big challenge, but the evolving regulatory landscape which partly also impacts the legacy products leads to additional efforts. While there is a lot of unclarity, e.g. related to the Notified Body Opinion, we have to be prepared.”
What current hot topic will you be addressing in your presentation and what would you say makes it relevant to 2019?
“My hot topics are based on two changes which will become relevant now. The first change is the increased oversight by Notified Bodies to Pre-Filled Syringes as these are single integral products for which Article 117 of the European Medical Device Regulation applies. The second change is the upcoming revision of the ISO 14971, the relevant standard for Risk Management for Medical Devices and Combination Products. Both topics impact Pre-filled syringes in development and from a post-market perspective.”
How would you like to see the PFS Europe market developing in the future and where do you think the biggest growth area will be in 2020?
“I think the market will have a growth by around 10% in sales per year over the next 5 years. I don’t see a very specific growth area, as both plastic and glass-based syringes will have similar growth.”
The full version of the interview and event brochure are available to download online at
Torsten Kneuss will be giving two presentations:
Day 1: “Design control for combination products.”
• Application of Design Controls to Combination Products – A global perspective
• Introduction to Design Controls for Combination Products
• Challenges with Design Controls for Combination Products
Day 2: “Risk management for combination products.”
• Introduction to Risk Management for Combination Products
• Typical pitfalls in the Risk Management for Combination Products
• Upcoming changes with ISO 1497: 2019
Pre-Filled Syringes and Injectable Drug Devices Conference
Main Conference: 15-16th January 2020
Pre-Conference Workshop: 14th January 2020
Location: Copthorne Tara Hotel, London, UK
For all media inquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email: firstname.lastname@example.org
45 Curlew Street
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exclusive interview from conference speaker Torsten Kneuss released ahead of SMi’s Pre-Filled Syringes and Injectable Drug Devices Conference here
News-ID: 1860019 • Views: 164
More Releases from SMI
RNA Therapeutics 2020 to Highlight Downregulating Therapeutic Technologies
SMi Reports: The morning session on day two of SMi’s RNA Therapeutics conference will pay a particular focus to “Downregulating Therapeutic Technologies”. SMi are proud to host the 11th annual RNA Therapeutics conference on February 19th – 20th 2020 in London. This year’s event will maintain a focus on the latest research and developments on delivery system technologies aimed at tackling difficult targets within the human body. An early
Registration closing soon for SMi’s Social Media in the Defence and Military S …
SMi reports: Two weeks left to secure your place at the upcoming 9th annual Social Media in the Defence Sector conference, taking place in London Taking place on 20th and 21st November, the 9th annual Social Media in the Defence Sector conference, taking place in London, will feature the biggest speaker line-up to date, with leading militaries at the cutting edge of social media innovation from the UK, USA, Canada, Italy,
Exclusive interview from conference speaker John Lisman released ahead of Parall …
SMi has released an exclusive interview with industry expert John Lisman, Attorney, Consultant and Trainer of Lisman Legal Life sciences B.V., ahead of the upcoming Parallel Trade conference this February. SMi’s Parallel Trade conference, taking place on 4th-5th February 2020 in London, will explore shortages of medicines, current and ongoing challenges posed by Parallel Trading, potential implications of Brexit and IP exhaustion rights. As the only B2B parallel trade conference in
Registration has opened for the 2020 edition of Defence Logistics Central and Ea …
SMi Group reports: Defence Logistics Central and Eastern Europe returns for it’s 5th successful year in March 2020 SMi Group presents the 5th annual Defence Logistics Central and Eastern Europe, taking place in Budapest, Hungary on 3rd and 4th March 2020. As the need for armed forces to enhance and maximise their logistical capacity continues to grow, and with the current political climate in Europe, it is now more important than ever
More Releases for Device
Walking Assist Device
The Walking Assist Device Market 2018 Industry Research Report focused on global and regional market, major manufacturers, as well as the current state of the Walking Assist Devicese industry. First, " Walking Assist Devicese Industry 2018" report analyzed the basic scope of this industry like definition, specification, classification, application, industry policy, news analysis and Walking Assist Devicese industry chain structure. Walking Assist Device Market Top Players Honda Motor Co., Ltd., Permobil
Molded Interconnect Device Market
Molded Interconnect Device Market-Global Industry Analysis and Forecast (2018-2026) by Process, Product Type, End-user application and geography Molded Interconnect Device Market was valued US$ 300 Mn in 2017 and is expected to reach US$ 890.5 Mn by 2026 at a CAGR of 14.57% during forecast period. Molded Interconnect Device market is segmented by process, product, end-user application and region. Increasing demand in electrical and mechanical application, rising use of Molded Interconnect Device
Medical Device Technologies Market - The Evolution of Medical Device Technologie …
The global medical device technologies market is anticipated to be boosted by various well-known players in the market. Some of these players that are dealing with the manufacturing of in vitro diagnostic devices hold a significant share in the global market. Whereas, the small market players are emerging from several developing nations, looking to set their foot in the market. Such measures are foreseen to change the market scenario in
Timing Device Market
Asia Pacific traffic sensor market is expected to hold the majority share due to the adoption of technologically-advanced systems. Growing urban population and the increasing need for real-time information systems in the region will propel the traffic sensor market growth. Growing urban population in countries including India, China, Japan, and South Korea is increasing the strain on the traffic management solutions. This is encouraging the governments to invest increasingly in
Neurorehabilitation Devices - MIME Robotic Device
Bioness Inc., Bionik Laboratories Corp., Bioxtreme, Denecor, Ectron Ltd., Ekso Bionics, Helius Medical Technologies, Hocoma AG, MagVenture A/S, Medtronic, Neuro Style, Rehab-Robotics Company Limited, Rehabtronics Inc, St Jude Medical Inc., Tyromotion are some of the prominent players at the forefront of competition in the global Neurorehabilitation Devices Market and are profiled in MRFR Analysis. Global Neurorehabilitation Devices Market - Overview The neurorehabilitation devices market is growing with the rapid pace. According
Global Medical Device Connectivity Market
Global Medical Device Connectivity Market, By Type (Integration Software, Connectivity Hardware (Wired, Wireless (Wi-Fi, WMTS, Bluetooth), By Applications (Electronic Medical Record, Patient Monitoring, Others), By End-User (Hospitals, Community Healthcare, Clinics, Others), By Geography (North America, Europe, Asia Pacific, South America, Middle East & Africa) – Industry Trends and Forecast to 2024 The Global Medical Device Connectivity Market has accounted for USD 5.7 billion in 2016 and is expected to reach